SIRT1 and breast cancer: In agreement with others, SIRT1 overexpression as a potential biomarker of poor prognosis in patients with BC is further supported by our observation in patients with H2BC, as the group with higher nuclear SIRT1 protein levels was significantly associated with a reduced DSS but not DFS.